Tissue-type plasminogen activator (t-PA): an agent with promise for selective thrombolysis
- 31 January 1985
- journal article
- editorial
- Published by Elsevier in International Journal of Cardiology
- Vol. 7 (1) , 82-86
- https://doi.org/10.1016/0167-5273(85)90181-0
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Thrombolysis, clot selectivity, and kinetics.Circulation, 1984
- Coronary thrombolysis: Pharmacological considerations with emphasis on tissue-type plasminogen activator (t-PA)Biochemical Pharmacology, 1984
- Hemorrhage and the products of fibrinogen digestion after intracoronary administration of streptokinase.Circulation, 1984
- Improvement of regional myocardial metabolism after coronary thrombolysis induced with tissue-type plasminogen activator or streptokinase.Circulation, 1984
- Coronary Thrombolysis with Tissue-Type Plasminogen Activator in Patients with Evolving Myocardial InfarctionNew England Journal of Medicine, 1984
- Coronary thrombolysis with intravenously administered human tissue-type plasminogen activator produced by recombinant DNA technology.Circulation, 1984
- Clot-Selective Coronary Thrombolysis with Tissue-Type Plasminogen ActivatorScience, 1983
- Cloning and expression of human tissue-type plasminogen activator cDNA in E. coliNature, 1983
- Fibrinolysis in the Animal OrganismNature, 1947
- THE FIBRINOLYTIC ACTIVITY OF HEMOLYTIC STREPTOCOCCIThe Journal of Experimental Medicine, 1933